Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (unaudited)

v3.26.3
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2024 $ 4 $ 870,503 $ (255) $ (730,694) $ 139,558
Balance, at beginning (in shares) at Dec. 31, 2024 4,385,929        
Issuance of common stock under the At-the-Market agreement, net of transactional expenses $ 3 59,840 59,843
Issuance of common stock under the At-the-Market agreement, net of transactional expenses (in shares) 2,741,887        
Repurchase of common stock under share repurchase program (including transactional expenses) (3,047) (3,047)
Repurchase of common stock under share repurchase program (including transactional expenses) (in shares) (250,000)        
Stock-based compensation 882 882
Foreign currency translation gain (loss) (11) (11)
Net loss (16,829) (16,829)
Ending balance, value at Mar. 31, 2025 $ 7 928,178 (266) (747,523) 180,396
Balance, at ending (in shares) at Mar. 31, 2025 6,877,816        
Beginning balance, value at Dec. 31, 2024 $ 4 870,503 (255) (730,694) $ 139,558
Balance, at beginning (in shares) at Dec. 31, 2024 4,385,929        
Repurchase of common stock under share repurchase program (including transactional expenses) (in shares)         (400,000)
Foreign currency translation gain (loss)         $ (19)
Net loss         (77,111)
Ending balance, value at Sep. 30, 2025 $ 10 1,039,212 (274) (807,805) 231,143
Balance, at ending (in shares) at Sep. 30, 2025 10,168,204        
Beginning balance, value at Mar. 31, 2025 $ 7 928,178 (266) (747,523) 180,396
Balance, at beginning (in shares) at Mar. 31, 2025 6,877,816        
Issuance of common stock under the At-the-Market agreement, net of transactional expenses $ 1 15,522 15,523
Issuance of common stock under the At-the-Market agreement, net of transactional expenses (in shares) 769,752        
Repurchase of common stock under share repurchase program (including transactional expenses) (2,902) (2,902)
Repurchase of common stock under share repurchase program (including transactional expenses) (in shares) (150,000)        
Issuance of commitment shares 1,837 1,837
Issuance of commitment shares (in shares) 48,708        
Stock-based compensation 1,423 1,423
Foreign currency translation gain (loss) (4) (4)
Net loss (28,272) (28,272)
Ending balance, value at Jun. 30, 2025 $ 8 944,058 (270) (775,795) 168,001
Balance, at ending (in shares) at Jun. 30, 2025 7,546,276        
Issuance of common stock under the At-the-Market agreement, net of transactional expenses $ 2 93,231 93,233
Issuance of common stock under the At-the-Market agreement, net of transactional expenses (in shares) 2,621,928        
Stock-based compensation 1,923 1,923
Foreign currency translation gain (loss) (4) (4)
Net loss (32,010) (32,010)
Ending balance, value at Sep. 30, 2025 $ 10 1,039,212 (274) (807,805) 231,143
Balance, at ending (in shares) at Sep. 30, 2025 10,168,204        
Beginning balance, value at Dec. 31, 2025 $ 13 1,100,141 (289) (854,715) 245,150
Balance, at beginning (in shares) at Dec. 31, 2025 12,788,069        
Issuance of common stock under the At-the-Market agreement, net of transactional expenses $ 1 20,125 20,126
Issuance of common stock under the At-the-Market agreement, net of transactional expenses (in shares) 1,411,449        
Employee stock purchase plan (ESPP) 79 79
Employee stock purchase plan (ESPP) (in shares) 5,883        
Stock-based compensation 1,970 1,970
Foreign currency translation gain (loss) 6 6
Net loss (40,194) (40,194)
Ending balance, value at Mar. 31, 2026 $ 14 1,122,315 (283) (894,909) 227,137
Balance, at ending (in shares) at Mar. 31, 2026 14,205,401        
Beginning balance, value at Dec. 31, 2025 $ 13 1,100,141 (289) (854,715) $ 245,150
Balance, at beginning (in shares) at Dec. 31, 2025 12,788,069        
Issuance of common stock upon exercise of stock option (in shares)         5,128
Foreign currency translation gain (loss)         $ (102)
Net loss         (134,075)
Ending balance, value at Sep. 30, 2026 $ 19 1,188,647 (391) (988,790) 199,485
Balance, at ending (in shares) at Sep. 30, 2026 19,150,163        
Beginning balance, value at Mar. 31, 2026 $ 14 1,122,315 (283) (894,909) 227,137
Balance, at beginning (in shares) at Mar. 31, 2026 14,205,401        
Issuance of common stock under the At-the-Market agreement, net of transactional expenses $ 3 33,486 33,489
Issuance of common stock under the At-the-Market agreement, net of transactional expenses (in shares) 2,585,400        
Issuance of common stock upon exercise of stock option 16 16
Issuance of common stock upon exercise of stock option (in shares) 1,516        
Stock-based compensation 2,256 2,256
Foreign currency translation gain (loss) (65) (65)
Net loss (40,552) (40,552)
Ending balance, value at Jun. 30, 2026 $ 17 1,158,073 (348) (935,461) 222,281
Balance, at ending (in shares) at Jun. 30, 2026 16,792,317        
Issuance of common stock under the At-the-Market agreement, net of transactional expenses $ 2 28,097 28,099
Issuance of common stock under the At-the-Market agreement, net of transactional expenses (in shares) 2,340,713        
Employee stock purchase plan (ESPP) 148 148
Employee stock purchase plan (ESPP) (in shares) 13,521        
Issuance of common stock upon exercise of stock option 36 36
Issuance of common stock upon exercise of stock option (in shares) 3,612        
Stock-based compensation 2,293 2,293
Foreign currency translation gain (loss) (43) (43)
Net loss (53,329) (53,329)
Ending balance, value at Sep. 30, 2026 $ 19 $ 1,188,647 $ (391) $ (988,790) $ 199,485
Balance, at ending (in shares) at Sep. 30, 2026 19,150,163